Magnets to the brain: a new test for steadier steps in old age
NCT ID NCT06779188
First seen Aug 28, 2026 · Last updated Aug 28, 2026
Summary
This trial tests whether transcranial magnetic stimulation (TMS) can improve balance in adults over 65 who have had falls. Participants receive either real TMS or a sham placebo over four weeks, five days a week. Researchers measure brain connectivity with EEG and balance with standard tests to see if TMS changes how brain areas communicate and whether that translates into steadier walking and standing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcranial magnetic stimulation (TMS), a non-invasive procedure that uses magnetic pulses to stimulate brain areas involved in balance.
- What this could lead to
- If TMS improves balance, it could offer a non-drug way to reduce falls and help older adults stay independent.
- What could go wrong
- This is an early, small trial. TMS may not produce lasting balance improvements, and effects could vary widely between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: a) Able to provide informed consent b) All ethnic groups c) \>65 years of age d) ≥2 non-injury falls or ≥1 injury fall in the past year \[17\]-\[21\] e) Absence of dementia/uncontrolled psychiatric disorder h) Able to walk and stand for 5 min continuously independently without assistance (i.e., cane, walker, ankle foot orthotics, electric scooter). i) Willingness to undergo MRI, participate in the 4-weeks intervention AND in the laboratory studies before, immediately-after, and 3-month after the intervention. Exclusion Criteria: 1. Inability to provide informed consent. 2. Non-English speaking. 3. Have contraindications to TMS based on TMS Adult Safety Screen (e.g., pregnancy, metal in the brain/skull, neurostimulator, pacemaker, infusion device, medication to treat mental illness) 4. Unintentional weight loss of ≥10 pounds over the past year. 5. Severe uncontrolled hypertension, or uncontrolled diabetes. 6. Poor cognitive status (Montreal Cognitive Assessment (MoCA) score ≥ 26) 7. Untreated depression or Geriatric Depression Scale score on 15 item scale \>7 8. History of limb amputation (upper or lower extremity) 9. Planned surgery in the next 3 months. 10. History of chemotherapy or planned chemotherapy in the next 6 months or active malignancy. 11. Severe osteoporosis, defined by diagnosis of osteoporosis with fracture. 12. Pregnant or have a chance of being pregnant. 13. Chronic inflammatory condition, autoimmune disease or infectious processes such as active tuberculosis, Human Immunodeficiency Virus, Rheumatoid arthritis, systemic lupus erythematosus, acute or chronic hepatitis B or C. 14. Illicit drug use 15. Use of medications that may increase the risk of falling: * Sedatives * Hypnotics * Anti-cholinergic * Benzodiazepines * Anti-depressants 16. Intracranial bleeds visible on their most recent CT or MRI scans.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Center for Neuromotor and Biomechanics Research at the University of Houston
RECRUITINGHouston, Texas, 77204, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skeletal muscle myosin binding protein c in fatigue and aging
- Longevity metrics AI/ML development study: a standing data library and Model-Development platform for predicting and validating health measurements, longevity, and disease
- Can Weight-Loss surgery weaken protein digestion in older adults?
- A plastic shell on the chest may help older adults with obesity breathe easier
- Protein plus exercise: a recipe to rebuild muscle while losing fat in older age?
- Zapping the brain to shift Decision-Making in depression and aging